AIRNA
PrivateLast Round
Series B
Apr 1, 2025
Total Funding Raised
$305M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
AIRNA is a biotechnology company that develops RNA-editing therapeutics to treat rare and common diseases by leveraging its proprietary RESTORE+™ platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AIRNA Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
AIRNA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 1, 2025 | ||||
| Series A Extension | Jul 31, 2024 | ||||
| Series A | Sep 19, 2023 |
AIRNA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LifeLink Ventures | Series B |
| Codon Capital | Series A |
| Forbion | Series B, Series A, Series A Extension |
| ARCH Venture Partners | Series B, Series A Extension, Series A |
| +ND Capital | Series B, Series A, Series A Extension |
| ARCH Venture Partners | Series B, Series A Extension, Series A |
| Alexandria Venture Investments | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 22, 2026
Developing new medicines for rare and common diseases, starting with AATD.
- Oct 1, 2025
Niru Subramanian appointed as the new COO.
AIRNA Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AIRNA's valuation, stock price, and market status.